companydata.dkcompanydata.dk

PHARMA PRODUCTION ApS: Financial statements 2025

CVR: 66108813

Source: annual report 2025, Danish Business Authority

01/10/2024 – 30/09/2025

PHARMA PRODUCTION ApS (CVR 66108813) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 19,077 and a net result of DKK -95,659 compared with DKK -20,470 the year before. That is a decrease of 87.8% compared with the year before. Equity in the 2025 report amounted to DKK 16,469,125. The solvency ratio was 65.1%.

Gross Profit
DKK 19,077
Profit/Loss
DKK -95,659
Equity
DKK 16,469,125
Total Assets
DKK 25,312,350

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-19 t.-96 t.16.5 mio.-
2024-156 t.-20 t.16.6 mio.0
2023-695 t.384 t.16.6 mio.1
2022-710 t.377 t.16.2 mio.1
2021-496 t.91 t.15.8 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMA PRODUCTION ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

PHARMA PRODUCTION ApS: The 2024 annual report is outApr 9, 2025

PHARMA PRODUCTION ApS has published its annual report for 2024. Gross profit came to DKK 155,799, and the net result was DKK -20,470.

About PHARMA PRODUCTION ApS

PHARMA PRODUCTION ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 1980. The company is registered under the industry Bogføring og revision; skatterådgivning. The company was previously named MEDICAPHARMA ApS and MATERIALISTEN GRAVENSGADE 8, AALBORG ApS. The management consists of Finn Jørgen Jensen. The company is owned by Bispensgade Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 19,077 and a net result of DKK -95,659 compared with DKK -20,470 the year before. Equity in the 2025 report amounted to DKK 16,469,125.

Source: annual report 2025, Danish Business Authority